Committee for Medicinal Products for Human Use of the European Medicine Agency Recommends FAMPYRA to Adult Patients with Multiple Sclerosis
Go back to Committee for Medicinal Products for Human Use of the European Medicine Agency Recommends FAMPYRA to Adult Patients with Multiple Sclerosis| Acorda Therapeutics, Inc. (NASDAQ: ACOR) | Delayed: 0.66 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.66 | 52 Week High | $43.63 | |||
| Open | $23.43 | 52 Week Low | $16.40 | |||
| Day High | $0.66 | P/E | 1.69 | |||
| Day Low | $0.66 | EPS | $0.39 | |||
| Volume | 141,661 | |||||
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 216.90 +2.55 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.35 | 52 Week High | $333.65 | |||
| Open | $217.76 | 52 Week Low | $223.02 | |||
| Day High | $219.12 | P/E | 27.77 | |||
| Day Low | $215.00 | EPS | $7.81 | |||
| Volume | 346,478 | |||||
